ECCO₂R therapy with the Hemolung RAS allows carbon dioxide to be removed from the blood independently of the lungs with the aim of facilitating the avoidance or reduction of intubation and invasive mechanical ventilation.
The first fully-integrated Respiratory Dialysis system, the Hemolung RAS combines advanced technology with user-centered design to provide simple, effective, and minimally invasive extracorporeal CO2 removal (ECCO2R).
Removing carbon dioxide and delivering oxygen directly to the blood allows the patient’s lungs to rest and heal while avoiding intubation and/or facilitating protective ventilation.
2014 – ALung treats first US Patient in emergency use.
ALung’s Hemolung RAS is currently undergoing an FDA PMA trial for clearance in the US (VENT-AVOID Trial).